WELCOME

Dear colleagues,

We are delighted to invite you to join us at the 2025 ESPE/OSCAR SCIENCE SYMPOSIUM.

The symposium will take place on 18 and 19 September, in Paris, France.

This fifth edition, jointly organized by the European Society for Paediatric Endocrinology (ESPE) and the French network for rare bone, calcium and cartilage diseases (OSCAR), will focus on the theme of Mineralization of bone and growth plate, towards the development of new therapies.

The symposium will address a wide range of key themes, including:

  • Genetic and developmental skeletal disorders
  • Advances in the understanding of short stature and bone growth
  • New insights into the role of the growth plate and innovative tools for bone analysis
  • Recent discoveries concerning vitamin D and its global impact
  • The use of teeth as models for the study of bone pathologies
  • Clinical and scientific approaches to fibrous dysplasia

In addition to these topics, the programme will include keynote presentations, a panel discussion and networking opportunities. It will offer a privileged setting to share your research and clini

cal expertise through oral presentations and posters covering a wide range of endocrine and bone diseases.

Paris, with its rich history and cultural heritage, will provide an inspiring backdrop for this event. By gathering in this iconic city, we look forward to engaging in interesting discussions and forging connections that will advance research and care.

For more information on the programme and to register for the 2025 ESPE/OSCAR Science Symposium, please visit our website.

We look forward to welcoming you to Paris!

On behalf of the Scientific and Local Organizing Committee
Prof. Agnès LINGLART, Le Kremlin-Bicêtre, France

Scientific and Local Organizing Committee

  • Agnès LINGLART I Scientific President, President, Prof. Pediatric Endocrinology & Diabetology; Head, Pediatric Endocrinology Dept.; Rare Metabolism Reference Center; Bicêtre Hospital AP‑HP; Univ. Paris‑Saclay; INSERM, Kremlin‑Bicêtre, France
  • Justine BACCHETTA, Prof. Pediatric Nephrology; Pediatric Nephrology–Rheumatology–Dermatology Unit; Rare Metabolism Reference Center, Hospices Civils de Lyon; Univ. Claude Bernard Lyon 1; INSERM UMR1033, Lyon, France
  • Claire BARDET, Prof. & Head, Orofacial Rare Diseases Research, INSERM UMR1333 Oral Health; Vice‑Dean Research, UFR Odontology; Univ. Paris Cité, France
  • Karelle BENISTAN Medical Geneticist, Coordinator of National Reference Centre for Non‑vascular Ehlers-Danlos Syndrome, Raymond Poincaré Hospital AP‑HP, Garches, France
  • Karine BRIOT, Professor of Rheumatology, Cochin Hospital AP‑HP & Université Paris‑Cité; Coordinator of Rare Calcium/Phosphate Metabolism Reference Centre, Paris, France
  • Mireille CASTANET, Pediatric Endocrinologist, Service of Pediatric Endocrinology & Diabetology, Rouen University Hospital; Coordinator of Rare Diseases Expert Center for Calcium and Phosphate Metabolism, University of Rouen Normandy, Rouen, France
  • Roland CHAPURLAT, Prof. Rheumatology; Head Dept. Rheumatology & Bone Diseases; Fibrous Dysplasia Reference Center; Hospices Civils de Lyon; Univ. Claude Bernard Lyon 1; INSERM UMR1033 LYOS, Lyon, France
  • Catherine CHAUSSAIN, Prof. Odontology, Oral Medicine Dept.; Rare Metabolism Reference Center, Bretonneau Hospital AP‑HP; Univ. Paris Cité; INSERM UMR1333, Paris, France
  • Martine COHEN-SOLAL, Prof. Rheumatology; Rare Bone Diseases Reference Center; Lariboisière Hospital AP‑HP; Univ. Paris Cité; INSERM UMR1132 BIOSCAR, Paris, France
  • Valérie CORMIER-DAIRE, Prof. Medical Genetics; Genomic Medicine for Rare Diseases, Necker Enfants‑Malades Hospital AP‑HP; Univ. Paris Cité; INSERM UMR1163, Imagine Institute, Paris, France
  • Maud DE DIEULEVEULT, INSERM Researcher, Institut Imagine, Paris, France
  • Thomas EDOUARD, Prof. Pediatric Endocrinology; Head, Pediatric Endocrinology & Bone Diseases Unit; Rare Metabolism Reference Center; Toulouse Children’s Hospital; Univ. of Toulouse; Filière OSCAR ERN BOND, France
  • Isabelle GENNERO, Responsible for Diagnostic Tests, Biochemistry Laboratory, CHU Toulouse, Paul Sabatier University, Toulouse, France
  • Pascal HOUILLIER, Head of the Physiology Department - Functional Explorations, Georges Pompidou Hospital AP‑HP, Univ. Paris Cité; Paris, France
  • Hervé KEMPF, INSERM Researcher; Head, CARPATH Team, UMR 7365 IMoPA Lab; CNRS; Univ. Lorraine, Nancy, France
  • Gilles LAVERNY, INSERM Researcher; Head, Vitamin D signaling subgroup; IGBMC CNRS UMR7104 / INSERM U1258; Univ. Strasbourg, France
  • Benoit MIOTTO, Research Director, UMR 8104 / U1016 – Institut Cochin (CNRS/INSERM/Université Paris Cité), Paris, France
  • Julien VAN GILS, Medical Geneticist, Department of Medical Genetics, Bordeaux University Hospital & University of Bordeaux, France
  • Frédéric VELARD, Research Engineer; Head, Bone Loss Research Subgroup, UR BIOS, Reims Champagne‑Ardennes Univ., France

About

The European Society for Paediatric Endocrinology (ESPE) is an international non-profit scientific organisation dedicated to improving the clinical care of children and adolescents with endocrine and metabolic conditions, including diabetes and rare bone disorders, through research, education, and the development of clinical standards. ESPE is a founding member of the International Consortium of Pediatric Endocrinology (ICPE) and actively promotes global collaboration in the field. Its mission is to advance excellence in paediatric endocrinology, diabetes, and bone disorders by fostering scientific discovery, medical education, and high-quality clinical care.

OSCAR - French rare diseases Healthcare Network: bone, cartilage and calcium diseases, officially designated and funded by the French Ministry of Health since 2014 under the National Rare Disease Plan.OSCAR is hosted by hôpital Bicêtre, Assistance Publique – Hôpitaux de Paris (AP-HP) and composed of reference centers and multidisciplinary teams. It promotes high-quality care pathways, develops national diagnostic and treatment guidelines, supports clinical and translational research, and provides educational and training programs within the national rare disease plan . The network is coordinated by Pr Agnès LINGLART.